詳細(xì)信息
- ;N-[3-[(4-氨基-6,7-二甲氧基-2-喹唑啉基)甲基氨基]丙基]四氫-2-呋喃甲酰胺鹽酸鹽;鹽酸阿呋唑嗪;
- Alfuzosine Hydrochloride
- ;alfuzosinehydrochloride;SL-77,499-10;MITTOVAL;N-[3-[(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLYNYL)METHYLAMINO]PROPYL]TETRAHYDRO-2-FURANCARBOXAMIDE;XATRAL;URION;UROXANTRAL;ALFUZOSIN HCL;ALFUZOSIN HYDROCHLORIDE;N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide, SL-77,499-10, Mittoval, Urion, Xatral;2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, hydrochloride;N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride;Uroxatral hydrochloride, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-;furancarboxamide hydrochloride;N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]oxol ane-2-carboxamide;2-Furancarboxamide;N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methyl amino)propyl)tetrahydro-;Alfuzosina [Spanish];Alfuzosine [French];Alfuzosinum [Latin];HSDB 7290;KBio3_001866;KBioGR_001616;N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahy dro-2-furancarboxamide;Prestwick0_000322;Prestwick1_000322;SL 77499;SPBio_000429;SPBio_002244;Spectrum2_000505;Spectrum3_001063;Spectrum4_001208;N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide hydrochloride (1:1);
- InChI=1/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
- 225℃
- 687.7°C at 760 mmHg
- 369.7°C
免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。